Literature DB >> 31893348

Acute headache management in emergency department. A narrative review.

Maria Adele Giamberardino1, Giannapia Affaitati1, Raffaele Costantini2, Martina Guglielmetti3,4, Paolo Martelletti5,6.   

Abstract

Headache is a significant reason for access to Emergency Departments (ED) worldwide. Though primary forms represent the vast majority, the life-threatening potential of secondary forms, such as subarachnoid hemorrage or meningitis, makes it imperative for the ED physician to rule out secondary headaches as first step, based on clinical history, careful physical (especially neurological) examination and, if appropriate, hematochemical analyses, neuroimaging or lumbar puncture. Once secondary forms are excluded, distinction among primary forms should be performed, based on the international headache classification criteria. Most frequent primary forms motivating ED observation are acute migraine attacks, particularly status migrainous, and cluster headache. Though universally accepted guidelines do not exist for headache management in an emergency setting, pharmacological parenteral treatment remains the principal approach worldwide, with NSAIDs, neuroleptic antinauseants, triptans and corticosteroids, tailored to the specific headache type. Opioids should be avoided, for their scarce effectiveness in the acute phase, while IV hydration should be limited in cases of ascertained dehydration. Referral of the patient to a Headache Center should subsequently be an integral part of the ED approach to the headache patients, being ascertained that lack of this referral involves a high rate of relapse and new accesses to the ED. More controlled studies are needed to establish specific protocols of management for the headache patient in the ED.

Entities:  

Keywords:  Drugs; Emergency department; Headache; Management; Migraine; Secondary headache

Mesh:

Substances:

Year:  2020        PMID: 31893348     DOI: 10.1007/s11739-019-02266-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  7 in total

1.  Acute Headache Management for Patients with Subarachnoid Hemorrhage: An International Survey of Health Care Providers.

Authors:  Carolina B Maciel; Brooke Barlow; Brandon Lucke-Wold; Arravintha Gobinathan; Zaid Abu-Mowis; Mounika Mukherjee Peethala; Lisa H Merck; Raffaele Aspide; Katie Dickinson; Guanhong Miao; Guogen Shan; Federico Bilotta; Nicholas A Morris; Giuseppe Citerio; Katharina M Busl
Journal:  Neurocrit Care       Date:  2022-08-02       Impact factor: 3.532

2.  "Triaging" Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies.

Authors:  Paolo Martelletti
Journal:  Pain Ther       Date:  2020-04-30

3.  Lost diagnoses in not otherwise specified headache in Emergency Department.

Authors:  Antonio Granato; Laura D'Acunto; Maria Elisa Morelli; Giulia Bellavita; Franco Cominotto; Paolo Manganotti
Journal:  Acta Neurol Belg       Date:  2021-08-27       Impact factor: 2.396

4.  Headache in the Neurological Emergency Department-High Degree of Inadequate Documentation Calls for Structured Assessments.

Authors:  Florian Rimmele; Josephine Janke; Peter Kropp; Ramon Kasch; Uwe Walter; Tim P Jürgens
Journal:  Front Neurol       Date:  2022-03-24       Impact factor: 4.003

Review 5.  The Relation between Persistent Post-Traumatic Headache and PTSD: Similarities and Possible Differences.

Authors:  Martina Guglielmetti; Gianluca Serafini; Mario Amore; Paolo Martelletti
Journal:  Int J Environ Res Public Health       Date:  2020-06-05       Impact factor: 3.390

6.  Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients.

Authors:  David García-Azorín; Javier Trigo; Blanca Talavera; Enrique Martínez-Pías; Álvaro Sierra; Jesús Porta-Etessam; Juan F Arenillas; Ángel L Guerrero
Journal:  Headache       Date:  2020-08-18       Impact factor: 5.887

7.  Cluster Headache is Still Lurking in the Shadows.

Authors:  Paolo Martelletti; Martina Curto
Journal:  Pain Ther       Date:  2021-06-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.